ML Research Intern, BS/MS - 2026 at Genesis Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, Drug Discovery, Artificial IntelligenceIndustries

Requirements

Currently enrolled in a Bachelor's or Master's program in Computer Science, Machine Learning, or a related technical field
A skilled and agile coder with a passion for writing clean, efficient, and reliable code
A curious and tenacious problem-solver, excited to tackle complex technical challenges
Eager to learn about the intersection of AI and biochemistry and the drug discovery process

Responsibilities

Contribute to a high-impact research project by building models, running experiments, and analyzing results for a key scientific challenge in generative AI
Turn research ideas into high-quality code, implementing and optimizing multi-modal models and algorithms from the latest literature
Design and run experiments at scale to validate promising approaches and hypotheses
Present your work and findings to the team, contributing to our collaborative research environment

Skills

Key technologies and capabilities for this role

Deep LearningGenerative AIDiffusion ModelsLLMsReinforcement LearningMulti-Modal ModelsMachine LearningComputational Chemistry

Questions & Answers

Common questions about this position

What is the salary for the ML Research Intern position?

This information is not specified in the job description.

Is this internship remote or does it require being in the office?

This information is not specified in the job description.

What skills are required for this ML Research Intern role?

Candidates should be currently enrolled in a Bachelor's or Master's program in Computer Science, Machine Learning, or a related field, skilled in writing clean, efficient, and reliable code, and demonstrate curiosity and tenacity as problem-solvers.

What is the team culture like at Genesis Therapeutics?

The team is a tight-knit group of deep learning researchers, software engineers, and drug discovery pioneers focused on revolutionary AI foundation models, with weekly paper discussions, research talks, and social events in a collaborative research environment.

What makes a strong candidate for this internship?

Exceptional students passionate about applying technical skills to challenging research problems at the intersection of AI and biochemistry, eager to learn about drug discovery, and ready to contribute directly to high-impact projects with mentorship.

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free